Results 161 to 170 of about 2,335,681 (277)

Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

Kidney International, 2014
A. Sinha, J. Bajpai, S. Saini, D. Bhatia, Aarti Gupta, Mamta Puraswani, A. Dinda, S. Agarwal, Shailaja Sopory, R. Pandey, P. Hari, A. Bagga   +11 more
semanticscholar   +1 more source

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor [PDF]

, 2010
Tracey J. Harvey, D. Burdon, Lynette P. Steele, Nicola Ingram, Geoffrey Hall, Peter J. Selby, R G Vile, Patricia A. Cooper, Steven D. Shnyder, John Chester   +9 more
openalex   +1 more source

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.

Kidney International, 2014
B. Meijers, R. Maas, B. Sprangers, K. Claes, R. Poesen, B. Bammens, M. Naesens, J. Deegens, R. Dietrich, M. Storr, J. Wetzels, P. Evenepoel, D. Kuypers   +12 more
semanticscholar   +1 more source

Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis. [PDF]

Kidney Dis (Basel), 2019
Sun P, Yu L, Huang J, Wang S, Zou W, Yang L, Liu G.   +6 more
europepmc   +1 more source

A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.

Kidney International, 2014
Takehiko Wada, M. Nangaku, S. Maruyama, E. Imai, Kumi Shoji, Sawako Kato, T. Endo, E. Muso, K. Kamata, H. Yokoyama, Keiji Fujimoto, Y. Obata, T. Nishino, Hideki Kato, S. Uchida, Y. Sasatomi, Takao Saito, S. Matsuo   +17 more
semanticscholar   +1 more source

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. [PDF]

, 1997
David Waltz, Lisa Natkin, Ross M. Fujita, Ying Wei, Harold A. Chapman   +4 more
openalex   +1 more source

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

Nature Medicine, 2011
Changli Wei, Shafic El Hindi, Jing Li, A. Fornoni, N. Goes, J. Sageshima, D. Maiguel, S. A. Karumanchi, H. Yap, M. Saleem, Qingyin Zhang, B. Nikolic, Abanti Chaudhuri, P. Daftarian, E. Salido, A. Torres, M. Salifu, M. Sarwal, F. Schaefer, C. Morath, V. Schwenger, M. Zeier, Vineet K Gupta, D. Roth, M. Rastaldi, G. Burke, P. Ruiz, J. Reiser   +27 more
semanticscholar   +1 more source

Urokinase Receptor Mediates Osteogenic Differentiation of Mesenchymal Stem Cells and Vascular Calcification via the Complement C5a Receptor

Stem Cells and Development, 2014
P. Kalbasi Anaraki, Margret Patecki, J. Larmann, S. Tkachuk, K. Jurk, H. Haller, G. Theilmeier, I. Dumler   +7 more
semanticscholar   +1 more source

Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer. [PDF]

Antibodies (Basel), 2019
Harel ET, Drake PM, Barfield RM, Lui I, Farr-Jones S, Van't Veer L, Gartner ZJ, Green EM, Lourenço AL, Cheng Y, Hann BC, Rabuka D, Craik CS.   +12 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictive Biomarker for Renal Failure Stratification and Urinary Tract Infections in Hemodialysis Patients

Karbala journal of Medicine Manager, Ahmed Hasen Kaser Alkarewy, Ali Jalil Ali Alyassery, Ahmed.hassen s.uokerbala.edu.iq   +3 more
openalex   +2 more sources